A normal A1C level for adults without diabetes is below 5.7%. A result between 5.7% and 6.4% indicates prediabetes, and 6.5% or higher on two separate tests meets the diagnostic threshold for type 2 diabetes, according to the American Diabetes Association’s 2026 Standards of Care. Unlike a fasting glucose test, which captures a single moment, A1C reflects your average blood sugar over the past two to three months — making it the most widely used test for both diagnosing and monitoring diabetes.
What A1C Actually Measures
Hemoglobin A1c measures the percentage of hemoglobin proteins in your red blood cells that have glucose attached to them — a process called glycation. Red blood cells live for roughly three months before being replaced, so the amount of glycated hemoglobin reflects your blood sugar exposure over that entire window, not just what you ate the morning of your test.
This is why A1C doesn’t require fasting. What you eat or drink right before your blood draw has no meaningful effect on the result, unlike a fasting glucose test, which can be thrown off by a single meal.
The A1C Range Chart
| A1C Result | Classification | What It Means |
|---|---|---|
| Below 5.7% | Normal | No indication of diabetes risk based on this marker |
| 5.7% – 6.4% | Prediabetes | Elevated risk; lifestyle intervention recommended |
| 6.5% or higher | Diabetes | Diagnostic threshold (confirmed on two separate tests) |
| Below 7% | Diabetes management target | Common treatment goal for most people already diagnosed |
These ranges apply broadly to nonpregnant adults. Pregnancy changes the picture significantly — the ADA’s 2026 guidelines recommend screening pregnant individuals before 15 weeks using a lower threshold of 5.9–6.4% to catch abnormal glucose metabolism earlier, since even modestly elevated levels carry real risk for pregnancy outcomes.
Does “Normal” A1C Change With Age?
The diagnostic thresholds themselves don’t shift by age — 5.7% and 6.5% apply whether you’re 25 or 65. What changes is risk and screening timing. The ADA now recommends diabetes and prediabetes screening begin at age 35 for the general population, repeated every three years if results are normal — or sooner, and at a younger age, for anyone with overweight, obesity, or other risk factors such as a family history of diabetes, high blood pressure, or a sedentary lifestyle.
In practice, this means A1C creeps upward gradually for many people as they age, even without a formal diagnosis — making a baseline test in your mid-30s genuinely useful for tracking your own trend line over time, not just comparing against a one-size-fits-all cutoff.
A1C and GLP-1 Medications (Ozempic, Wegovy, Mounjaro, Zepbound)
If you’re starting or currently taking a GLP-1 medication, A1C is one of the most important labs to track, and for three distinct reasons:
- Before starting therapy — most prescribers want a baseline A1C to confirm prediabetes or diabetes, assess your starting blood sugar control, and help determine appropriate dosing
- While on therapy — retesting every 3–6 months shows whether the medication is actually lowering your blood sugar, and by how much, making it the clearest objective measure of whether treatment is working
- If you’re self-pay or using telehealth — many GLP-1 telehealth providers require a recent A1C result before writing or renewing a prescription
Our Hemoglobin A1c Blood Test is $50 with a physician lab order included — no insurance or doctor’s visit required, and results are typically available within 24–48 hours.
How Reliable Is A1C Alone?
A1C is highly sensitive but imperfect on its own. A large analysis of the 2023 ADA screening recommendation found the criteria had 95% sensitivity but only 27% specificity — meaning it correctly flags nearly everyone with dysglycemia, but also flags many people who don’t ultimately have diabetes, particularly when used as a single broad screening tool rather than alongside fasting glucose. This is part of why a single elevated A1C is treated as a flag for follow-up testing, not an automatic diagnosis.
For a more complete metabolic picture alongside A1C, many people pair it with a Comprehensive Metabolic Panel, which adds fasting glucose, kidney function, and electrolyte balance in the same draw.
Who Should Get an A1C Test
- Adults age 35 and older, as a routine screening baseline
- Anyone younger than 35 with overweight, obesity, or other diabetes risk factors
- People with a family history of type 2 diabetes
- Anyone with prediabetes risk factors who hasn’t been tested in the past 3 years
- People starting or actively managing GLP-1 therapy
- Anyone already diagnosed with diabetes, for ongoing monitoring (typically every 3 months)
Order Your A1C Test Today
Skip the waiting room and get your baseline. Order the Hemoglobin A1c Blood Test online, visit any of 4,000+ Labcorp locations nationwide, and get results delivered to your private account in 24–48 hours. No fasting required, no insurance needed, and it’s fully HSA/FSA eligible.
Frequently Asked Questions
What is a normal A1C level? A normal A1C for adults without diabetes is below 5.7%. Between 5.7% and 6.4% is classified as prediabetes, and 6.5% or higher on two separate tests meets the diagnostic threshold for type 2 diabetes.
Does A1C change as you get older? The diagnostic ranges themselves don’t change with age, but average A1C tends to drift upward gradually over time for many people, which is why the ADA recommends starting routine screening at age 35 and repeating it every 3 years.
Do I need to fast before an A1C test? No. Unlike a fasting glucose test, A1C reflects your average blood sugar over roughly the past 3 months, so recent food or drink doesn’t meaningfully affect the result.
How often should A1C be tested? People already diagnosed with diabetes are typically tested every 3 months to monitor treatment. People with prediabetes or risk factors are generally tested once or twice a year, and average-risk adults are screened roughly every 3 years starting at age 35.
Can A1C alone diagnose diabetes? A single elevated A1C is a strong signal but is typically confirmed with a second test before a formal diagnosis. Research on ADA screening criteria shows very high sensitivity but more modest specificity, meaning some people flagged for follow-up will not ultimately be diagnosed with diabetes.